Clinical Utility of Serum Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Concentrations in the Assessment of Liver Fibrosis due to Chronic Hepatitis B

By Liang B   Li Y   Zhao A   Xie F   Guo Z  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 631-639

Field House Publishing

Access to resources Recommend Favorite

Progress in the Development of Matrix Metalloproteinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1388-1395

Bentham Science Publishers

Access to resources Recommend Favorite

The Clinical Potential of Matrix Metalloproteinase Inhibitors in the Rheumatic Disorders

By Elliott S.   Cawston T.  

Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

The Evolution of the Matrix Metalloproteinase Inhibitor Drug Discovery Program at Abbott Laboratories

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 12, 2004-08 ,pp. : 1255-1267

Bentham Science Publishers

Access to resources Recommend Favorite

Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis

By Su W   Gao F   Lu J   Wu W   Zhou G   Lu S  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 986-994

Field House Publishing

Access to resources Recommend Favorite